Atlas Trials

Personalized Rituximab Treatment Based on Artificial Intelligence in Membranous Nephropathy (iRITUX)

Clinical trial NCT06341205 · RECRUITING

Trial details

NCT number
NCT06341205
Sponsor
Centre Hospitalier Universitaire de Nice
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Membranous Nephropathy
Start date
2025-02-04
Primary completion
2031-08-31
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.